WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

Reuters

Published

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

Full Article